Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

Post time 1 hour(s) ago

journal：Journal of Clinical Oncology

Authors：Zhenwei Peng; Wenzhe Fan; Bowen Zhu; Guoying Wang; Junhui Sun; Chengjiang Xiao; Fuxi Huang; Rong Tang; Yu Cheng; Zhen Huang; Yuchuang Liang; Huishuang Fan; Liangliang Qiao; Fuliang Li; Wenquan Zhuang; Baogang Peng; Jiping Wang; Jiaping Li; Ming Kuang

Published date：2023-1-1

DOI：10.1200/jco.22.00392

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00392

Article link：https://doi.org/10.1200/jco.22.00392

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

Post time 1 hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Other] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)